We are live on ! Find out more
CCM

Cinctive Capital Management Portfolio holdings

AUM $1.53B
1-Year Est. Return 48.83%
This Fund
S&P 500
This Quarter Est. Return
+7.89%
1 Year Est. Return
+48.83%
3 Year Est. Return
+143.95%
5 Year Est. Return
+199.46%
10 Year Est. Return
–
AUM
$1.85B
AUM Growth
-$244M
Cap. Flow
-$327M
Cap. Flow %
-17.69%
Top 10 Hldgs %
21.39%
Holding
559
New
166
Increased
84
Reduced
128
Closed
176

Top Buys

Rank Stock Value
1
CVX icon
Chevron
CVX
+$29.9M
2
VST icon
Vistra
VST
+$25M
3
EXAS
Exact Sciences
EXAS
+$24.7M
4
TEAM icon
Atlassian
TEAM
+$24.3M
5
CVLT icon
Commault Systems
CVLT
+$22.2M

Top Sells

Rank Stock Value
1
K
Kellanova
K
+$30.5M
2
FLR icon
Fluor
FLR
+$26.8M
3
VRNA
Verona Pharma
VRNA
+$23.6M
4
INFA
Informatica
INFA
+$20.8M
5
MPC icon
Marathon Petroleum
MPC
+$18.4M

Sector Composition

Rank Sector Weight
1 Technology 21.45%
2 Financials 14.44%
3 Consumer Discretionary 13.32%
4 Healthcare 13.12%
5 Energy 8.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TXG icon
326
10x Genomics
TXG
$6.09B
$555K 0.03%
34,019
-10,084
-23% -$152K
BTU icon
327
Peabody Energy
BTU
$2.65B
$527K 0.03%
17,739
-90,915
-84% -$2.67M
AVAV icon
328
AeroVironment
AVAV
$7.93B
$522K 0.03%
+2,160
New +$679K
UBER icon
329
Uber
UBER
$145B
$511K 0.03%
+6,257
New +$563K
CNR
330
Core Natural Resources Inc
CNR
$4.04B
$495K 0.03%
+5,597
New +$477K
MLTX icon
331
MoonLake Immunotherapeutics
MLTX
$1.49B
$490K 0.03%
+37,194
New +$439K
SVCO
332
Silvaco Group
SVCO
$268M
$466K 0.03%
115,000
+25,000
+28% +$124K
COLM icon
333
Columbia Sportswear
COLM
$3B
$453K 0.02%
8,226
-8,646
-51% -$462K
TBN
334
Tamboran Resources
TBN
$1.14B
$451K 0.02%
+16,569
New +$421K
VMC icon
335
Vulcan Materials
VMC
$36.2B
$446K 0.02%
+1,564
New +$459K
OI icon
336
O-I Glass
OI
$1.12B
$443K 0.02%
30,000
-342,787
-92% -$4.53M
DXCM icon
337
DexCom
DXCM
$32.7B
$432K 0.02%
6,507
-59,641
-90% -$3.86M
CYTK icon
338
Cytokinetics
CYTK
$10.2B
$417K 0.02%
6,562
-99,079
-94% -$6.16M
TVTX icon
339
Travere Therapeutics
TVTX
$5.02B
$415K 0.02%
10,849
-83,807
-89% -$2.73M
URGN icon
340
UroGen Pharma
URGN
$1.88B
$398K 0.02%
+16,991
New +$369K
BEAM icon
341
Beam Therapeutics
BEAM
$2.68B
$397K 0.02%
+14,318
New +$365K
DJT icon
342
Trump Media & Technology Group
DJT
$2.78B
$384K 0.02%
+28,972
New +$395K
FDX icon
343
FedEx
FDX
$72.8B
$381K 0.02%
+1,318
New +$346K
AZN icon
344
AstraZeneca
AZN
$239B
$375K 0.02%
2,040
-59,221
-97% -$10.4M
WST icon
345
West Pharmaceutical
WST
$24.4B
$371K 0.02%
1,350
-12,969
-91% -$3.55M
COP icon
346
ConocoPhillips
COP
$145B
$360K 0.02%
+3,841
New +$347K
ADBE icon
347
Adobe
ADBE
$101B
$359K 0.02%
+1,025
New +$349K
PEP icon
348
PepsiCo
PEP
$190B
$355K 0.02%
+2,474
New +$364K
PSN icon
349
Parsons
PSN
$5.05B
$346K 0.02%
+5,600
New +$438K
RYTM icon
350
Rhythm Pharmaceuticals
RYTM
$6.85B
$345K 0.02%
3,225
-31,931
-91% -$3.39M
12 13
14
15 16

Similar funds

MCP
Meridiem Capital Partners Dallas, Texas $1.53B AUM 17.03% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
FI
FJ Investments Salt Lake City, Utah $1.53B AUM 27.51% 1-Year Est. Return
FBB
Fulton Breakefield Broenniman Bethesda, Maryland $1.53B AUM 18.11% 1-Year Est. Return
SG
Sienna Gestion Paris, France $1.53B AUM 27.73% 1-Year Est. Return
CET
Clean Energy Transition London, United Kingdom $1.54B AUM 34.41% 1-Year Est. Return
HR
Howe & Rusling Rochester, New York $1.53B AUM 21.45% 1-Year Est. Return
CCP
Cryder Capital Partners London, United Kingdom $1.53B AUM 9.36% 1-Year Est. Return

Cinctive Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, Cinctive Capital Management held 559 positions worth $1.85B, down 12% from $2.09B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Cinctive Capital Management withdrew a net $327M in Q4 2025, closing 176 positions and reducing 128 holdings. Its most notable exit was Kellanova, an estimated $30.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Cinctive Capital Management opened a new position in Atlassian worth $25.1M.

  • Cinctive Capital Management's largest Q4 2025 buy was Atlassian: 154,988 shares worth $25.1M.
  • Cinctive Capital Management added most to Chevron in Q4 2025, an estimated $29.9M increase.
  • Cinctive Capital Management's biggest Q4 2025 reduction was CSX Corp, cutting an estimated $17.5M.
  • Cinctive Capital Management fully exited Kellanova in Q4 2025, selling an estimated $30.5M.
  • Cinctive Capital Management's ten largest holdings make up 21% of its $1.85B portfolio in Q4 2025.
  • Cinctive Capital Management opened 166 new positions and closed 176 in Q4 2025.
  • Cinctive Capital Management's portfolio value fell 12% quarter-over-quarter to $1.85B.

Based on Cinctive Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.